within Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B02B_VitaminKAndOtherHemostatics.B02BD05_CoagulationFactorVii;

model CoagulationFactorVii
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_2C(
    weight = 70,
    F = 1,
    Cl = 5.833333333333333e-08,
    adminDuration = 600,
    adminMass = 90 / 1000000,
    adminCount = 1,
    Vd = 0.00019,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    Vdp = 0.00028000000000000003,
    k12 = 7.194444444444444e-08,
    k21 = 7.194444444444444e-08);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>CoagulationFactorVii</td></tr><tr><td>ATC code:</td><td>B02BD05</td></tr><td>route:</td><td>intravenous</td></tr>
    <tr><td>compartments:</td><td>2</td></tr>
    <tr><td>dosage:</td><td>90</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>0.19</td><td>L</td></tr>
    <tr><td>clearance:</td><td>3.0</td><td>mL/kg/h</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Coagulation factor VII (recombinant activated factor VII, rFVIIa) is a protein used to promote hemostasis in patients with hemophilia A or B with inhibitors to factor VIII or IX, as well as in other rare bleeding disorders. It is approved for use in bleeding episodes and surgical interventions to aid in blood clotting.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adults following a single intravenous dose of recombinant activated factor VII (rFVIIa).</p><h4>References</h4><ol></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.B.B02BD05 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end CoagulationFactorVii;
